本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Cullinan Therapeutics

21.82
+0.14000.65%
盤後21.820.00000.00%19:30 EDT
成交量:61.74萬
成交額:1,350.25萬
市值:14.04億
市盈率:-6.29
高:22.37
開:21.62
低:21.16
收:21.68
52周最高:22.54
52周最低:5.68
股本:6,435.47萬
流通股本:4,808.28萬
量比:0.80
換手率:1.28%
股息:- -
股息率:- -
每股收益(TTM):-3.4680
每股收益(LYR):-3.7236
淨資產收益率:-50.30%
總資產收益率:-31.36%
市淨率:4.36
市盈率(LYR):-5.86

資料載入中...

2026/08/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/13

重要事件披露

Form 8-K - Current report
2026/08/07

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/06

重要事件披露

Form 8-K - Current report
2026/07/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/16

重要事件披露

Form 8-K - Current report
2026/06/10

重要事件披露

Form 8-K - Current report
2026/06/08

重要事件披露

Form 8-K - Current report
2026/05/18

重要事件披露

Form 8-K - Current report
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/07

重要事件披露

Form 8-K - Current report
2026/05/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/10

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/10

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/10

重要事件披露

Form 8-K - Current report
2026/03/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities